Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning

The level of Epstein-Barr virus DNA in blood has proven to be a biomarker with some predictive value in allogeneic hematopoietic stem cell transplantation patients (HSCT). We evaluated the impact of EBV load on survival of 51 patients (32M/19F, median age: 32 years, from < 1 to 68 years old), who...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Li, Qin, Rane, Lalit, Poiret, Thomas, Zou, Jiezhi, Magalhaes, Isabelle, Ahmed, Raija, Du, Ziming, Vudattu, Nalini, Meng, Qingda, Gustafsson-Jernberg, Åsa, Winiarski, Jacek, Ringdén, Olle, Maeurer, Markus, Remberger, Mats, Ernberg, Ingemar
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper: Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5058676/
https://ncbi.nlm.nih.gov/pubmed/27102298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8803
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars